Quantum Biopharma (QNTM) Non Operating Income (2022 - 2024)

Quantum Biopharma (QNTM) reported Non Operating Income of -$10371.0 for Q3 2024, down 2829.21% on a YoY basis from $380.0 in Q4 2023, and down 2829.21% sequentially from $380.0 in Q3 2023.

Quantum Biopharma (QNTM) Non Operating Income (2022 - 2024) Analysis & Trends

Quantum Biopharma (QNTM) has 3 years of Non Operating Income data on file, last reported at -$10371.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -9.22 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 5.75 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -8.59 Mn
10 Quantum Biopharma 13.00 Bn 13.00 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -10,371.00
Sep 30, 2023 380.00
Sep 30, 2022 16,052.00